logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Galectin-1

UniprotKB/SwissProt ID: LEG1_HUMAN (P09382)

Gene Name: LGALS1

Organism: Homo sapiens (Human).

Function: May regulate apoptosis, cell proliferation and cell differentiation. Binds beta-galactoside and a wide array of complex carbohydrates. Inhibits CD45 protein phosphatase activity and therefore the dephosphorylation of Lyn kinase. Strong inducer of T-cell apoptosis.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Secreted, extracellular space, extracellular matrix.

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR001079
IPR008985
IPR013320
IPR015535

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1GZW X-ray 1.70 A A/B2-134Link
1W6M X-ray 2.30 A A/B4-135Link
1W6N X-ray 1.65 A A/B4-134Link
1W6O X-ray 1.90 A A/B4-134Link
1W6P X-ray 1.80 A A/B4-134Link
1W6Q X-ray 2.10 A A/B2-134Link
2KM2 NMR - A/B2-135Link
2ZKN X-ray 1.86 A A/B4-135Link
3OY8 X-ray 2.19 A A/B2-135Link
3OYW X-ray 2.50 A A/B2-135Link
3T2T X-ray 1.90 A A/B1-135Link
3W58 X-ray 1.58 A A/B/C/D2-135Link
3W59 X-ray 2.10 A A/B/C/D2-135Link

The S-nitrosylation sites of LEG1_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
143LNLGKDSNNL C LHFNPRFNAH EEECCCCCCE E EEEEEEECCC 2.78%HC0522178444-
243LNLGKDSNNL C LHFNPRFNAH EEECCCCCCE E EEEEEEECCC 2.78%HC052212679in vitro
343LNLGKDSNNL C LHFNPRFNAH EEECCCCCCE E EEEEEEECCC 2.78%HC0520140087in vivo
461NAHGDANTIV C NSKDGGAWGT CCCCCCCEEE E ECCCCCCCCC 4.15%HC0622178444-
561NAHGDANTIV C NSKDGGAWGT CCCCCCCEEE E ECCCCCCCCC 4.15%HC062212679in vitro
661NAHGDANTIV C NSKDGGAWGT CCCCCCCEEE E ECCCCCCCCC 4.15%HC0618335467-
761NAHGDANTIV C NSKDGGAWGT CCCCCCCEEE E ECCCCCCCCC 4.15%HC0619366988-
861NAHGDANTIV C NSKDGGAWGT CCCCCCCEEE E ECCCCCCCCC 4.15%HC0620140087in vivo
9131MAADGDFKIK C VAFD------ EEEEEEEEEE E EEEC 2.80%HC0222126794in vivo